Pr Daniel BUSER, DDS

Chirurgien-dentiste

Berne, Suisse

Biographie

Dr. Daniel Buser is one of the most experienced international implant surgeons with 35 years of surgical experience, and he is one of the pioneers of Guided Bone Regeneration (GBR). He has performed the first GBR surgery at the University of Bern in October 1988.

He has been Professor of Oral Surgery at the University of Bern/Switzerland (2000-19). He also served as President of various academic associations including the EAO (1996/97), and the ITI (2009- 13).

He received several scientific awards, among others the André Schroeder Research Prize by the ITI (1995), the Daniel M. Laskin Award (1996) by the AAOMS, the Honorary Membership Award by the AAP (1997), the Brånemark Osseointegration Award by the AO (2013), and the ITI Honorary Fellowship (2017).

With his team, he has been active in pre-clinical and clinical research in the field implant surfaces, bone augmentation with GBR, bone grafts and bone substitutes, and anatomical studies using CBCT. He has authored and co-authored more than 400 publications and book chapters in the field of implant dentistry. He is also Editor and main author of the GBR Book by Quintessence, which was published as 3rd edition in 2022.

Today, he works part time in a private Centre for Implantology in Bern to surgically treat implant patients. His main activity is Continuing Education. With his friend Toni Sculean, he has established 2020 the Buser & Sculean Academy for Periodontology and Implant Dentistry. The mission is global knowledge sharing with the young generation of implant specialists around the globe using a high-quality streaming technology. Thus, he continues to widely lecture at national and international conferences.


Interventions de Pr Daniel BUSER, DDS

https://schema.org/OfflineEventAttendanceMode
https://schema.org/EventScheduled
France
  • <p><strong>💫 Soirée exceptionnelle avec le Pr&nbsp;Daniel BUSER organisée conjointement par le&nbsp;Study Club 75 et le Study Club Paris,&nbsp;ouverte&nbsp;et gratuite&nbsp;à tous les membres ITI à jour de leur cotisation (305€/an - cotisation degressive jusqu'à 3 ans). La cotisation ITI vous permet notamment d'accéder gratuitement à des centaines d'événements de study clubs dans le monde entier, et aux ouvrages en ligne ITI Treatment Guides. Pour en savoir plus:&nbsp;<a href="https://www.iti.org/community/become-a-member" rel="nofollow">consultez le site ITI.ORG</a></strong><strong><br></strong></p> <p><strong>⚠️ Inscription obligatoire sur <a href="https://www.iti.org/events/event-search/event/-/event-detail/hybrid-design-implant-pr-daniel-buser/244612" rel="nofollow">le site Internet de l'ITI</a> - PLACES GRATUITES TRÈS LIMITÉES</strong><br><strong><br></strong></p> <p>The term<em> Hybrid Design (HD)</em> was first used by Dennis Tarnow in 1993. The term stands for an implant with a micro-rough implant surface in the endosseous portion to promote faster and better osseointegration of the implant during healing and during function and a smooth, machined surface in the neck/collar region for the transcrestal area with contact to the peri-implant sulcus. The most prominent HD implant is the iconic Tissue Level (TL) Implant by Straumann, which was first inserted in patients in 1986 at the University of Bern (Buser et al. 1988).<br></p> <p>Clinical long-term studies with TL implants have clearly documented the least risk for the development of peri-implant mucositis and peri-implantitis (Derks et al. 2016a; Derks et al. 2016b) when compared with implants with a micro-rough surface, all the way up to the implant neck. The long-term documentation at the University of Bern confirmed the low risk of roughly 3% for developing peri-implantitis with TL implants in a large 10-year study with 500+ TL implants (Buser et al. 2012). A most recent study by Windael et al. (2021) with 1478 non-HD implants and a 10-year observation period confirmed this again. Implants with an early bone loss (EBL) ≥0.5 mm during the first year of function showed a 5x times higher odds ratio for future peri-implantitis development. EBL of &gt;0.5 mm means an exposure of the micro-rough surface to the peri-implant sulcus.<br><br>This lecture will present all relevant aspects of HD implants and what surgical factors are essential to achieve successful outcomes with good long-term stability. In addition, the latest development of the Straumann implant will be presented, the TLX and TLC implants both with a Hybrid Design. It represents the 4th Generation of Straumann implants.<strong><br><br>Learning Objectives:</strong><br><br>-&nbsp;Understand the concept of Hybrid Design Implants<br>-&nbsp;Understand why HD implants have a reduced risk for the development of peri-implantitis&nbsp;over time<br>-&nbsp;Learn about the surgical key factors for successful outcomes with HD implants with good&nbsp;long-term stability<br>-&nbsp;Learn about the TLX and TLC implants, their indications, and clinical application.<br><br><br><strong></strong></p> <ul></ul> <ul></ul> <p></p>
    • Paris
    • 23 Rue Édouard VII
      France
    Jan
    17

    2024

    Hybrid Design Implants: Are they the Future in Implant De...

    Paris
    ITI France - International Team for Implantology
    https://schema.org/OfflineEventAttendanceMode
    https://schema.org/EventScheduled
    France
  • <p>Nous avons l’immense privilège d’accueillir le Pr Daniel BUSER le vendredi 23 septembre pour une journée exceptionnelle en petite comité chez Practisdental. <br>Le Pr Daniel Buser est professeur et président du département de chirurgie buccale de l’Université de Berne en Suisse depuis 2000. Il a été président de diverses associations académiques, dont l’Association européenne pour l’ostéointégration (EAO) en 1996/97, la Société suisse d’implantologie orale (SSOI) en 1999-2002, la Société suisse de chirurgie buccale et de stomatologie (SSOS) en 2002- 07. Il a également été président de l’ITI (2009-13), la plus grande association mondiale dans le domaine de la dentisterie implantaire. Ses principaux domaines de recherche sont la technologie de surface, la stabilité à long terme des implants dentaires, la régénération des tissus autour des implants dentaires et la régénération osseuse guidée. Il est auteur et co-auteur de plus de 350 publications, qui sont très citées, et de plusieurs manuels, dont deux livres GBR et plusieurs guides de traitement ITI. Il donne de nombreuses conférences lors de conférences nationales et internationales.<br>Fort de ses 35 années d’expérience en implantologie, le professeur Buser abordera les aspects chirurgicaux garantissant le succès de nos traitements dans les zones esthétiques chez des patients partiellement édentés.La conférence sera orientée vers la clinique.<br>Les critères de sélection actuels pour les différentes options de traitement dans diverses indications cliniques seront abordées conforté par des suivis et des résultats d’études à long terme.<br>Pour plus d’information: <a href="https://www.practisdental.com/journee-formation/&lt;br&gt;&lt;br&gt;&lt;br&gt;Pour" rel="nofollow">https://www.practisdental.com/...</a> vous inscrire, <a href="https://my.weezevent.com/daniel-buser" rel="nofollow">https://my.weezevent.com/danie...</a></p>
    • Villefranche-sur-Saône
    • 596 Boulevard Albert Camus
      France
    Sep
    23

    2022

    Procédures chirurgicales chez les patients édentés partiels

    Villefranche-sur-Saône
    Practisdental
    https://schema.org/OfflineEventAttendanceMode
    https://schema.org/EventScheduled
    France
    • Toulouse
    • 11 Esplanade Compans Caffarelli
      France
    Juin
    08

    2017

    SFPIO Congrès international de Toulouse 2017

    Toulouse
    SFPIO - Société Française de Parodontologie et ...